Literature DB >> 7319608

Control of rheumatic fever in developing countries.

K B Sharma, K Prakash.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7319608     DOI： 10.1007/bf02825019

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  18 in total

1.  Streptococcal infection, rheumatic fever and rheumatic heart disease among 500 Jewish school schildren in Teheran.

Authors:  R A Gharagozloo; E Margolis; H Marcus; A P Ala; R Jafari; H Nezam
Journal:  Isr J Med Sci       Date:  1972-01

2.  Infections with beta-Hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin.

Authors:  J M Dixon; A E Lipinski
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

3.  The antibody respones in man to infection with different serotypes of group-A streptococci.

Authors:  J P Widdowson; W R Maxted; C M Notley; A M Pinney
Journal:  J Med Microbiol       Date:  1974-11       Impact factor: 2.472

4.  Distribution of groups and types of beta haemolytic streptococci in cases of rheumatic heart disease and apparently healthy school children.

Authors:  K Prakash; S Chawda; B P Amma; K B Sharma
Journal:  Indian J Pathol Bacteriol       Date:  1973-10

5.  Epidemiology and prophylaxis of rheumatic fever in Delhi--a five year follow-up.

Authors:  S Padmavati; K B Sharma; O Jayaram
Journal:  Singapore Med J       Date:  1973-09       Impact factor: 1.858

6.  Community control of rheumatic heart disease in developing countries: 1 a major public health problem.

Authors: 
Journal:  WHO Chron       Date:  1980-09

7.  Rheumatic fever and rheumatic heart disease in developing countries.

Authors:  S Padmavati
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

8.  Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers.

Authors:  E N Fox; R H Waldman; M K Wittner; A A Mauceri; A Dorfman
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Enhanced resistance to streptococcal infection induced in mice by cell wall mucopeptide.

Authors:  J Rotta; T J Prendergast; W W Karakawa; C K Harmon; R M Krause
Journal:  J Exp Med       Date:  1965-11-01       Impact factor: 14.307

10.  Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans.

Authors:  E N Fox; M K Wittner; A Dorfman
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.